Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Filamon LTD
Varian, a Siemens Healthineers Company
Novartis
PMV Pharmaceuticals, Inc
Pfizer
AstraZeneca
Novartis
Kivu Bioscience Inc.
Hoffmann-La Roche
Eli Lilly and Company
AstraZeneca
BeOne Medicines
Bayer
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
ViroMissile, Inc.
Replimune Inc.
Terremoto Biosciences Inc.
Jazz Pharmaceuticals
Carevive Systems, Inc.
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
Angiex, Inc.
Incyte Corporation
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Iambic Therapeutics, Inc
AstraZeneca
General Oncology, Inc.
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
SN BioScience
Guerbet
Takeda
EXoPERT
Adela, Inc
Gene Solutions
Orano Med LLC
Second Life Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Jacobio Pharmaceuticals Co., Ltd.